Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile?
The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged≥40 years. We reviewed our data in our ovulation indu...
Saved in:
Published in | Human reproduction (Oxford) Vol. 11; no. 5; pp. 1109 - 1112 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.05.1996
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged≥40 years. We reviewed our data in our ovulation induction with IUI programme for 168 consecutive patients aged ≥40 years undergoing a total of 469 cycles of treatment. Either sequential clomiphene citrate and human menopausal gonadotrophins or daily gonadotrophins were utilized along with timed IUI insemination. In 402 completed cycles, 28 clinical pregnancies occurred. The pregnancy loss rate was 34.4%. The overall ongoing/viable pregnancy rates per initiated and completed cycles were 4.47 and 5.22% respectively. No viable pregnancies occurred in 136 cycles in women aged ≥43 years. The ongoing/viable cycle fecundity rates for women aged 40, 41, and 42 years were 9.6, 5.2, and 2.4% percycle respectively. When utilized in women aged≥40 years, ovulation induction with IUI is most likely to result in successful pregnancy in women 40–42 years of age. Women≥43 years should consider other alternatives such as adoption or egg donation. |
---|---|
AbstractList | The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged >/=40 years. We reviewed our data in our ovulation induction with IUI programme for 168 consecutive patients aged >/=40 years undergoing a total of 469 cycles of treatment. Either sequential clomiphene citrate and human menopausal gonadotrophins or daily gonadotrophins were utilized along with timed IUI insemination. In 402 completed cycles, 28 clinical pregnancies occurred. The pregnancy loss rate was 34.4%. The overall ongoing/viable pregnancy rates per initiated and completed cycles were 4.47 and 5.22% respectively. No viable pregnancies occurred in 136 cycles in women aged >/=43 years. The ongoing/variable cycle fecundity rates for women aged 40, 41, and 42 years were 9.6, 5.2, and 2.4% per cycle respectively. When utilized in women aged >=40 years, ovulation induction with IUI is most likely to result in successful pregnancy in women 40-42 years of age. Women >/=43 years should consider other alternatives such as adoption or egg donation. The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged≥40 years. We reviewed our data in our ovulation induction with IUI programme for 168 consecutive patients aged ≥40 years undergoing a total of 469 cycles of treatment. Either sequential clomiphene citrate and human menopausal gonadotrophins or daily gonadotrophins were utilized along with timed IUI insemination. In 402 completed cycles, 28 clinical pregnancies occurred. The pregnancy loss rate was 34.4%. The overall ongoing/viable pregnancy rates per initiated and completed cycles were 4.47 and 5.22% respectively. No viable pregnancies occurred in 136 cycles in women aged ≥43 years. The ongoing/viable cycle fecundity rates for women aged 40, 41, and 42 years were 9.6, 5.2, and 2.4% percycle respectively. When utilized in women aged≥40 years, ovulation induction with IUI is most likely to result in successful pregnancy in women 40–42 years of age. Women≥43 years should consider other alternatives such as adoption or egg donation. Abstract The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged≥40 years. We reviewed our data in our ovulation induction with IUI programme for 168 consecutive patients aged ≥40 years undergoing a total of 469 cycles of treatment. Either sequential clomiphene citrate and human menopausal gonadotrophins or daily gonadotrophins were utilized along with timed IUI insemination. In 402 completed cycles, 28 clinical pregnancies occurred. The pregnancy loss rate was 34.4%. The overall ongoing/viable pregnancy rates per initiated and completed cycles were 4.47 and 5.22% respectively. No viable pregnancies occurred in 136 cycles in women aged ≥43 years. The ongoing/viable cycle fecundity rates for women aged 40, 41, and 42 years were 9.6, 5.2, and 2.4% percycle respectively. When utilized in women aged≥40 years, ovulation induction with IUI is most likely to result in successful pregnancy in women 40-42 years of age. Women≥43 years should consider other alternatives such as adoption or egg donation. The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged >/=40 years. We reviewed our data in our ovulation induction with IUI programme for 168 consecutive patients aged >/=40 years undergoing a total of 469 cycles of treatment. Either sequential clomiphene citrate and human menopausal gonadotrophins or daily gonadotrophins were utilized along with timed IUI insemination. In 402 completed cycles, 28 clinical pregnancies occurred. The pregnancy loss rate was 34.4%. The overall ongoing/viable pregnancy rates per initiated and completed cycles were 4.47 and 5.22% respectively. No viable pregnancies occurred in 136 cycles in women aged >/=43 years. The ongoing/variable cycle fecundity rates for women aged 40, 41, and 42 years were 9.6, 5.2, and 2.4% per cycle respectively. When utilized in women aged >=40 years, ovulation induction with IUI is most likely to result in successful pregnancy in women 40-42 years of age. Women >/=43 years should consider other alternatives such as adoption or egg donation. |
Author | Trias, A. Trout, S. Corsan, G. Kemmann, E. |
Author_xml | – sequence: 1 givenname: G. surname: Corsan fullname: Corsan, G. organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Reproductive Endocrinology & Infertility, UMDNJ-Robert Wood Johnson Medical School 303 George Street, Suite 250, New Brunswick, New Jersey 08901, USA – sequence: 2 givenname: A. surname: Trias fullname: Trias, A. organization: Centro Medico Docente La Trinidad, Av. Intercomunal La Trinidad, EI Hatillo, Apdo. Postal 80474 Caracas 1080-A, Venezuela – sequence: 3 givenname: S. surname: Trout fullname: Trout, S. organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Reproductive Endocrinology & Infertility, UMDNJ-Robert Wood Johnson Medical School 303 George Street, Suite 250, New Brunswick, New Jersey 08901, USA – sequence: 4 givenname: E. surname: Kemmann fullname: Kemmann, E. organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Reproductive Endocrinology & Infertility, UMDNJ-Robert Wood Johnson Medical School 303 George Street, Suite 250, New Brunswick, New Jersey 08901, USA |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3120779$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/8671400$$D View this record in MEDLINE/PubMed |
BookMark | eNqVUMFu1DAUtFBR2RY-AckH4JbFjhPHRkIIrYAiVi2HIiEu1ktssy6JvbUTtv17DAkrceRij-fNPI_mDJ344A1CzylZUyLZy3BnQ9Q3YYoe-rTeTUM0-zUQKhnhD9CKVpwUJavJCVqRkouCUk4fobOUbgjJUPBTdCp4QytCVuj26ufUw-iCx87rqfuDujC0zhuND27cZX6MMI0mZio_khmc_-vAhzAYjyuC7w3EhIPF8N1g8BqHXpv4CruE3Zhlcdwddq43bx6jhzYHN0-W-xx9ef_uenNRbK8-fNy83RZdJelYgAVWMya4tm2XqYysFSzH1lQSUst8gDRMWt3qhnBdt1LzkoIE0Yga2Dl6Me_dx3A7mTSqwaXO9D14E6akGlHSqmE0C1_Pwi6GlKKxah_dAPFeUaJ-V67-rVzNlaul8ux_unw0tYPRR_fScZ4_W-aQOuhtBN-5dJQxWpKmkVkmZlmY9v-doJitLo3m7miG-EPxhjW1uvj6TV1uri-3ovqsPrFf8c24hw |
CODEN | HUREEE |
CitedBy_id | crossref_primary_10_1016_j_rbmo_2011_11_007 crossref_primary_10_1007_s00129_007_2052_1 crossref_primary_10_1016_S1472_6483_10_61069_3 crossref_primary_10_1016_j_bpobgyn_2006_09_004 crossref_primary_10_1016_j_gyobfe_2010_02_014 crossref_primary_10_1016_S1521_6934_02_00146_3 crossref_primary_10_1007_s12522_016_0241_0 crossref_primary_10_1007_s10815_008_9273_7 crossref_primary_10_1016_S0015_0282_02_03168_0 crossref_primary_10_1016_j_gyobfe_2007_02_028 crossref_primary_10_1016_j_fertnstert_2006_08_024 crossref_primary_10_1016_j_fertnstert_2004_05_032 crossref_primary_10_1016_S0889_8529_03_00046_X crossref_primary_10_1007_s10815_013_9980_6 crossref_primary_10_1016_j_maturitas_2011_07_003 crossref_primary_10_1016_S0015_0282_00_01631_9 crossref_primary_10_1515_ijamh_2021_0073 crossref_primary_10_1016_S0015_0282_97_81514_2 crossref_primary_10_1007_s10304_013_0578_y crossref_primary_10_36106_ijsr_1638275 crossref_primary_10_1007_s10815_020_01976_3 crossref_primary_10_1080_1464770312331368923 crossref_primary_10_1016_S0015_0282_99_00300_3 crossref_primary_10_1016_S0015_0282_02_03212_0 crossref_primary_10_1016_S0368_2315_10_70027_2 crossref_primary_10_1111_j_1479_828X_2010_01232_x crossref_primary_10_1016_j_maturitas_2014_02_014 crossref_primary_10_1016_j_fertnstert_2009_02_040 crossref_primary_10_1007_s15006_012_0928_z crossref_primary_10_1007_s10815_022_02551_8 crossref_primary_10_1016_S0301_2115_99_00260_2 |
ContentType | Journal Article |
Copyright | European Society for Human Reproduction and Embryology 1996 1996 INIST-CNRS |
Copyright_xml | – notice: European Society for Human Reproduction and Embryology 1996 – notice: 1996 INIST-CNRS |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1093/oxfordjournals.humrep.a019306 |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1460-2350 |
EndPage | 1112 |
ExternalDocumentID | 10_1093_oxfordjournals_humrep_a019306 8671400 3120779 10.1093/oxfordjournals.humrep.a019306 ark_67375_HXZ_NCTNL84P_K |
Genre | Journal Article |
GroupedDBID | --- -E4 .2P .55 .GJ .I3 .XZ .ZR 0R~ 1TH 29I 2WC 3O- 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6.Y 70D AABJS AABMN AABZA AACZT AAESY AAIMJ AAIYJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AASNB AAUQX AAVAP AAVLN AAWDT AAYOK ABEUO ABIXL ABJNI ABKDP ABMNT ABNHQ ABNKS ABPTD ABQLI ABQTQ ABSAR ABSMQ ABWST ABXVV ABZBJ ACCCW ACFRR ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEIU ADEYI ADEZT ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEJOX AEKPW AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFGWE AFIYH AFOFC AFXAL AFXEN AFYAG AGINJ AGKEF AGKRT AGQXC AGSYK AGUTN AHMBA AHXPO AIJHB AIKOY AIMBJ AJEEA AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ANFBD APIBT APWMN AQDSO AQKUS AQVPL ARIXL ASAOO ASMCH ASPBG ATDFG ATTQO AVNTJ AVWKF AWCFO AXUDD AYOIW AZFZN AZQFJ BAWUL BAYMD BCRHZ BEYMZ BGYMP BHONS BQDIO BSCLL BSWAC BTRTY BVRKM BYORX BZKNY C1A C45 CAG CASEJ CDBKE COF CS3 CXTWN CZ4 DAKXR DFGAJ DIK DILTD DPORF DPPUQ DU5 D~K E3Z EBS EE~ EIHJH EJD ELUNK EMOBN ENERS F5P F9B FECEO FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ IOX J21 JXSIZ KAQDR KBUDW KC5 KOP KQ8 KSI KSN L7B M-Z M49 MBLQV MBTAY MHKGH ML0 N9A NGC NLBLG NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OBOKY OCZFY ODMLO OHT OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO TCN TCURE TEORI TJX TLC TMA TR2 W8F WH7 WOQ X7H X7M YAYTL YKOAZ YXANX ZGI ZKX ZXP ~91 AAUAY ABQNK ADQBN ATGXG AANRK AAPBV AAUGY ABPTK ABXZS ALXQX H13 IQODW OBFPC AGMDO CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c491t-afa353386dfbcc49386ff83714d190059900a9e39fdbd706d5b9d621a9a8785a3 |
ISSN | 0268-1161 |
IngestDate | Fri Aug 16 23:50:31 EDT 2024 Thu Sep 12 18:11:27 EDT 2024 Thu May 23 23:48:55 EDT 2024 Sun Oct 29 17:08:25 EDT 2023 Wed Sep 11 04:52:16 EDT 2024 Sun Mar 31 11:38:07 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | intrauterine insemination age ovulation induction fertility Human Prognosis Indication Induction Artificial insemination Assisted procreation Age 40-49 Female Female sterility Ovulation |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c491t-afa353386dfbcc49386ff83714d190059900a9e39fdbd706d5b9d621a9a8785a3 |
Notes | ark:/67375/HXZ-NCTNL84P-K ArticleID:11.5.1109 3To whom correspondence should be addressed istex:37BDCF7BCDD3F7BBF779A37A134706470F0B9C8F ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://academic.oup.com/humrep/article-pdf/11/5/1109/1937627/11-5-1109.pdf |
PMID | 8671400 |
PQID | 78214731 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_78214731 crossref_primary_10_1093_oxfordjournals_humrep_a019306 pubmed_primary_8671400 pascalfrancis_primary_3120779 oup_primary_10_1093_oxfordjournals_humrep_a019306 istex_primary_ark_67375_HXZ_NCTNL84P_K |
PublicationCentury | 1900 |
PublicationDate | 1996-05-01 |
PublicationDateYYYYMMDD | 1996-05-01 |
PublicationDate_xml | – month: 05 year: 1996 text: 1996-05-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford – name: England |
PublicationTitle | Human reproduction (Oxford) |
PublicationTitleAlternate | Hum Reprod |
PublicationYear | 1996 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | 9043930 - Hum Reprod. 1997 Jan;12(1):199 |
References_xml | |
SSID | ssj0016186 |
Score | 1.737813 |
Snippet | The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased... Abstract The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has... |
SourceID | proquest crossref pubmed pascalfrancis oup istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1109 |
SubjectTerms | Adult age Biological and medical sciences Birth control Chorionic Gonadotropin - therapeutic use Clomiphene - therapeutic use Female fertility Gynecology. Andrology. Obstetrics Humans Infertility - therapy Insemination, Artificial, Homologous intrauterine insemination Male Maternal Age Medical sciences Menotropins - therapeutic use Middle Aged Ovulation Induction Pregnancy Pregnancy Outcome Pregnancy, High-Risk Retrospective Studies Sterility. Assisted procreation |
Title | Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile? |
URI | https://api.istex.fr/ark:/67375/HXZ-NCTNL84P-K/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/8671400 https://search.proquest.com/docview/78214731 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKJk1ICEHHRIGBH6AvXTLnO-EFTdVYBWxMopMqXiI7cbQItRlNCiu_jJ_HtZ24KSpo20uUWrIb557YvtfH5yL0miYuceBLMBhh4KBEPDIoY8zgLkuo7TtJKLU7T8_80YX7YeJNOp3fLdbSomJm8mvjuZK7WBXKwK7ilOwtLKsbhQK4B_vCFSwM1xvZ-POPOvnWADxrJQMrOOLg7Dak8lzEbkXWhlyqg5RCSqSpodQXBi4ZLAHuktIhCDwikl6I3N0iWJCXg7waSB7hz0sh4bTOA1RbAEIYs2j-X8iXXivGvI4xDIt5qQKtJ6YOFcD7UZmQW0XFQs4JX8zVPDCd1mmcj81VhEKRmhs-YD2Q2T54qpYSXTe5Gmhdnxi2o0Rn9UhstRDntYZVIYvamqJhfLY3Dv9KGquQvaztVJqXiym8B5PCYtYhG2S3_5oONUlRbc878XpzsWourpu7h7btIPKE238y0eQimYVARfdUz3fQm_r5Dv_7dGuro23xoV83Jy8fXNESPttM5Vv5t0MkF0bjR-hh7dHgIwXPx6jDZ120ewQwK6ZL3MeSYyw3b7po57SmcnRR_1yJpi8P8Hh1BrA8kDW0nPpyF33XKMca5bhBORYox22U4zbK4QeWKMcuwRLluMgwGBcDyrFE-Vuclziv8Arj756gi_fH4-HIqBOFGIkbWZVBM-qA2xL6acYSKIK7LAuFFmUK612hQEQIjbgTZSlLA-KnHotS37ZoRMMg9Kizh7ZmxYw_RRj8bd_iKacuF7JPQWhRm9opuCWEE-pZPeQ3BoqvlB5MfCOg9FBfmlPXovNvglQZePFo8jU-G47PPoXuefyxhyyw920b319Dh67tWDYJgqiHXjVoiWH6EHuCdMaLRRmDg2C5gQP92lMg0lWF8CVM8M_u2uHn6P5qMHiBtqr5gu_DAr5iL-W38gdD2fn4 |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ovulation+induction+combined+with+intrauterine+insemination+in+women+40+years+of+age+and+older%3A+is+it+worthwhile%3F&rft.jtitle=Human+reproduction+%28Oxford%29&rft.au=Corsan%2C+G.&rft.au=Trias%2C+A.&rft.au=Trout%2C+S.&rft.au=Kemmann%2C+E.&rft.date=1996-05-01&rft.issn=0268-1161&rft.eissn=1460-2350&rft.volume=11&rft.issue=5&rft.spage=1109&rft.epage=1112&rft_id=info:doi/10.1093%2Foxfordjournals.humrep.a019306&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_oxfordjournals_humrep_a019306 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0268-1161&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0268-1161&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0268-1161&client=summon |